1. Home
  2. TBI vs ABOS Comparison

TBI vs ABOS Comparison

Compare TBI & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

N/A

Current Price

$3.74

Market Cap

129.9M

ML Signal

N/A

Logo Acumen Pharmaceuticals Inc.

ABOS

Acumen Pharmaceuticals Inc.

N/A

Current Price

$3.16

Market Cap

155.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TBI
ABOS
Founded
1985
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
129.9M
155.7M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
TBI
ABOS
Price
$3.74
$3.16
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$6.00
$7.50
AVG Volume (30 Days)
266.0K
277.9K
Earning Date
05-21-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
61.39
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$6.25
N/A
Revenue Next Year
$3.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.44
$0.86
52 Week High
$7.78
$3.50

Technical Indicators

Market Signals
Indicator
TBI
ABOS
Relative Strength Index (RSI) 36.03 64.16
Support Level $3.44 $1.21
Resistance Level $5.56 N/A
Average True Range (ATR) 0.25 0.25
MACD -0.00 0.01
Stochastic Oscillator 29.52 78.33

Price Performance

Historical Comparison
TBI
ABOS

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

About ABOS Acumen Pharmaceuticals Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.

Share on Social Networks: